Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study of Combined Platelet Transfusion
Sponsor: The General Hospital of Western Theater Command
Summary
Platelet transfusion is an irreplaceable and important treatment method for clinical prevention and treatment of thrombocytopenia or platelet dysfunction. Due to various factors, it is difficult to achieve platelet ABO complete homotypic transfusion in clinical practice. When ABO-compatible platelets cannot be obtained, plasma-reduced platelets, platelets with low anti-A or anti-B titers are often used in clinical practice to reduce the risk of ABO-incompatible platelet-compatible transfusion reactions. The combined platelets prepared in this study can achieve ABO primary and secondary side compatible infusion.
Official title: Combined Platelet Transfusion:A Single-arm, Open, Prospective, Non-inferiority Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
86
Start Date
2024-08-01
Completion Date
2025-10-28
Last Updated
2024-09-26
Healthy Volunteers
Yes
Conditions
Interventions
Combined platelets
1 therapeutic dose combined platelet contained no less than 2.5 ×10\^11 platelets as a quality standard.
Locations (1)
Li Zhang
Chengdu, Sichuan, China